FdaApplication
ANDA 065421
Identifiers
- fda_app_no: ANDA065421
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2008-05-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIFAMPIN | RIFAMPIN | 600MG/VIAL | INJECTABLE;INJECTION |
1 product